664 Collins Street, Docklands, Melbourne, Australia
The Australia China Business Council (ACBC) Victoria invites you to attend their event to explore the opportunities represented by Australia’s life sciences sector where 84 per cent of life sciences companies are SMEs.
In 2018, Australia is positioned within the world’s top five countries in biotechnology and is expected to again surpass US$200 million in total value deal making activity of the $50 billion market cap life sciences sector.
Technological innovation, knowledge and networking are the drivers of productivity in today’s enlightened world and Australia has the expertise and ballast in these areas to leverage to advantage companies in or entering this sector.
At this event, you’ll hear from investment experts:
- Duncan Niven, Director of Research, Pitcher Partners
- Matt McNamara, Chief Investment Officer, Bioscience Managers Pty Ltd
- Eric Gao, Founder/Director, BMY Group
Duncan Niven will provide an insight into asset allocation and the investment markets within Australia. He will also explore how the markets go about investing and the types of opportunities for growth and prosperity Pitcher Partners seek to help their clients attain through their independent investment advice.
As the CEO of dedicated investment firm, Bioscience Managers, Matt McNamara will highlight some of their recent successful and currently open opportunities. Based on a philosophy of investing in innovative science and technology that will transform healthcare, Matt will share the Bioscience Managers’ vision to deliver you impressive investment returns.
Eric Gao, BMY Group, will provide expert opinion and case study insights from the perspective of venture fund capital raising.
The speakers’ presentations will be followed by a moderated panel discussion with audience Q&A.
Date: Thursday 30 August 2018
Venue: Pitcher Partners, Level 13, 664 Collins Street, Docklands, Melbourne
Time: 12.15 pm for 12.30 pm to 2 pm
Cost: $55 for ACBC members, $95 for non-members